Mayo Clinic

Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium (2017) Barrdahl M, Rudolph A, Hopper JL, Southey MC, Broeks A, Fasching P, Beckmann M, et al. Journal article Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women (2017) Kadalayil L, Khan S, Nevanlinna H, Fasching P, Couch FJ, Hopper JL, Liu J, et al. Journal article Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, et al. Journal article Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity (2017) Fasching P, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, et al. Journal article BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer (2017) Shimelis H, Mesman RLS, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calleja FMGR, et al. Journal article Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (2017) Glubb DM, Johnatty SE, Quinn MCJ, O'Mara TA, Tyrer JP, Gao B, Fasching P, et al. Journal article TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) Fagerholm R, Khan S, Schmidt MK, Garcia-Closas M, Heikkila P, Saarela J, Beesley J, et al. Journal article Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 (2017) Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, El Zimaity H, et al. Journal article Immobilization for carbon ion beam ablation of cardiac structures in a porcine model (2017) Prall M, Eichhorn A, Richter D, Lehmann HI, Constantinescu A, Kaderka R, Lugenbiel P, et al. Journal article Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, et al. Journal article